❌

Normal view

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study

Nature Cancer, Published online: 15 May 2026; doi:10.1038/s43018-026-01172-9

Jayaram et al. assessed the performance of the combination of circulating tumor DNA and serum prostate-specific antigen for dynamic monitoring of metastatic prostate cancer at first-line treatment in this prospective observational clinical trial.
  • ✇Nature Cancer
  • AI for breast cancer screening Allan Hackshaw · Rosalind Given-Wilson
    Nature Cancer, Published online: 10 March 2026; doi:10.1038/s43018-025-01109-8Whether support from artificial intelligence (AI) models improves breast screening is a topic of research in national cancer screening programmes and clinical oncology. Three studies now show that AI tools can assist radiologists with evaluating mammograms, substantially reducing workloads and possibly improving screening performance.
     

AI for breast cancer screening

10 March 2026 at 08:00

Nature Cancer, Published online: 10 March 2026; doi:10.1038/s43018-025-01109-8

Whether support from artificial intelligence (AI) models improves breast screening is a topic of research in national cancer screening programmes and clinical oncology. Three studies now show that AI tools can assist radiologists with evaluating mammograms, substantially reducing workloads and possibly improving screening performance.
❌